藍帆醫療(002382.SZ):旗下武漢必凱爾及湖北高德是特斯拉所有車型車載急救包全球供應商
格隆匯5月2日丨有投資者在投資者互動平台向藍帆醫療(002382.SZ)提問,“公司急救包業務號稱亞洲第一,請問公司是否統計過公司急救包銷售佔中國出口比例巨頭是多少?根據海關最新統計數據,湖北急救包出口金額約佔全國22.5%”
藍帆醫療回覆稱,公司旗下的武漢必凱爾及其子公司湖北高德是特斯拉所有車型車載急救包全球供應商,在海外與德國平治、寶馬、奧迪、法國雷諾等所有車企,國內與傳統車、新能源車等著名車企建立業務合作,此外還與滴滴出行、招商銀行、中國人壽、平安保險等知名企業達成合作,為其提供急救包定製解決方案。公司的急救包產品銷往德國、英國等全球多個國家,在全球醫療急救包市場中市場份額排名前列。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.